Live from the NIH registry
Studies recruiting near San Antonio right now
Top 25 of 1,023 recruiting studies, sorted by proximity — each links to its official registry page
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Retina Consultants of Texas — Schertz, Texas (16.5 mi)
· Sponsor: Genentech, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: National Cancer Institute (NCI)
Using SnapshotNIR With Provocative Leg Maneuver for PAD Assessment
Peripheral Arterial Disease
N/A
Observational 150 participants sought
University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Kent Imaging Inc
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care - South San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: R1 Therapeutics
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — San Antonio, Texas (3.3 mi)
· Sponsor: Dren Bio
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
Diabetic Macular Edema
Phase 1, Phase 2
Interventional 49 participants sought
Medical Center Ophthalmology Associates — San Antonio, Texas (3.3 mi)
· Sponsor: Boehringer Ingelheim
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: SWOG Cancer Research Network
PAS-004 in Patients With Advanced Solid Tumors
RAS Mutation, NF1 Mutation
Phase 1
Interventional 48 participants sought
NEXT Oncology — San Antonio, Texas (3.3 mi)
· Sponsor: Pasithea Therapeutics Corp.
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Texas Oncology - San Antonio ( Site 8009) — San Antonio, Texas (3.3 mi)
· Sponsor: Merck Sharp & Dohme LLC
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Lewy Body Dementia Psychosis
Phase 2
Interventional 180 participants sought
The University of Texas Health Science Center San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
Element Research Group — San Antonio, Texas (3.3 mi)
· Sponsor: Philip Morris Products S.A.
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
START San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Hypoparathyroidism
Phase 3
Interventional 160 participants sought
MBX Biosciences Investigational Site — Shavano Park, Texas (8.6 mi)
· Sponsor: MBX Biosciences
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Asthma
Phase 3
Interventional 440 participants sought
Research Site — San Antonio, Texas (3.3 mi)
· Sponsor: AstraZeneca
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
Chronic Kidney Disease
Phase 2
Interventional 465 participants sought
Clinical Advancement Center — San Antonio, Texas (3.3 mi)
· Sponsor: Novo Nordisk A/S
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — San Antonio, Texas (3.3 mi)
· Sponsor: AstraZeneca
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 710 participants sought
Texas Oncology San Antonio Medical Center — San Antonio, Texas (3.3 mi)
· Sponsor: Daiichi Sankyo
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Solid Tumor Cancer, Locally Advanced
Phase 1, Phase 2
Interventional 480 participants sought
Avenzo Therapeutics Recruiting Site — San Antonio, Texas (3.3 mi)
· Sponsor: Avenzo Therapeutics, Inc.
TMS for PTSD in Youth
Post Traumatic Stress Disorder (PTSD)
N/A
Interventional 20 participants sought
UT Health Department of Psychiatry — San Antonio, Texas (3.3 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Sleep Wake Disorders, Sleep Disorders, Circadian Rhythm
Phase 3
Interventional 70 participants sought
Vanda Investigational Site — San Antonio, Texas (3.3 mi)
· Sponsor: Vanda Pharmaceuticals
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Breast Cancer
Phase 2
Interventional 36 participants sought
Texas Oncology- San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: SCRI Development Innovations, LLC
Evaluating Treatments for Suicidal Veterans With PTSD
Self-directed Violence, Post-traumatic Stress Disorder (PTSD)
N/A
Interventional 125 participants sought
South Texas Health Care System, San Antonio, TX — San Antonio, Texas (3.3 mi)
· Sponsor: VA Office of Research and Development
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
Solid Tumor, Adult, Metastatic Breast Cancer
Phase 1
Interventional 392 participants sought
University of Texas San Antonio (UTSA) — San Antonio, Texas (3.3 mi)
· Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
The University of Texas Health Science Center at San Antonio — San Antonio, Texas (3.3 mi)
· Sponsor: Jaeb Center for Health Research
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — San Antonio, Texas (3.3 mi)
· Sponsor: Sameek Roychowdhury